Todd Andrew Theman, MD
Plastic and Reconstructive Surgery · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
- Since medical school
- 17 years
- Harvard Medical School, 2009
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Theman’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A137182 · Current
Licensed to practise in California · since 2015 · expires 2027-04-30 · Harvard Medical School.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$2,175
Pharmacies billed $2,175 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 52% of their Part D prescriptions (150 of 287) in 2024. Above the middle of the specialty; the typical plastic and reconstructive surgery clinician is at 28%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
286 generic and fewer than 11 brand-name prescriptions · $2,175 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tramadol | 105 | $571 | $5 |
| Ibuprofen | 71 | $540 | $8 |
| Oxycodone | 45 | $293 | $7 |
| Tizanidine | 11 | $187 | $17 |
| Meloxicam | 29 | $174 | $6 |
Year by year
| 2024 | 287 | 136 | 52% (150) | None | $2,175 |
| 2023 | 236 | 137 | 54% (128) | 0% | $2,441 |
| 2022 | 310 | 164 | 46% (141) | 0% | $2,777 |
| 2021 | 325 | 145 | 41% (132) | None | $3,344 |
| 2020 | 289 | 126 | 41% (119) | None | $3,390 |
| 2019 | 252 | 175 | 66% (166) | 6% | $3,599 |
| 2018 | 214 | 134 | 58% (123) | None | $2,423 |
| 2017 | 175 | 104 | 48% (84) | None | $2,917 |
| 2016 | 115 | 67 | 48% (55) | None | $897 |
| 2015 | 30 | 18 | 43% (13) | 0% | $408 |
| 2014 | 22 | 12 | 50% (11) | None | $253 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Diclofenac | 18 | $608 | $34 |
| Tramadol | 91 | $500 | $5 |
| Ibuprofen | 58 | $449 | $8 |
| Hydrocodone-Acetaminophen | 21 | $148 | $7 |
| Oxycodone | 13 | $92 | $7 |
2022: 6 drugs
| Tramadol | 113 | $656 | $6 |
| Diclofenac | 22 | $596 | $27 |
| Ibuprofen | 64 | $493 | $8 |
| Hydrocodone-Acetaminophen | 24 | $179 | $7 |
| Meloxicam | 24 | $171 | $7 |
| Gabapentin | 24 | $136 | $6 |
2021: 6 drugs
| Tramadol | 79 | $446 | $6 |
| Ibuprofen | 53 | $411 | $8 |
| Gabapentin | 55 | $362 | $7 |
| Hydrocodone-Acetaminophen | 42 | $313 | $7 |
| Tizanidine | 15 | $213 | $14 |
| Meloxicam | 22 | $150 | $7 |
2020: 5 drugs
| Gabapentin | 82 | $580 | $7 |
| Hydrocodone-Acetaminophen | 61 | $474 | $8 |
| Ibuprofen | 47 | $378 | $8 |
| Tramadol | 52 | $304 | $6 |
| Meloxicam | 15 | $90 | $6 |
2019: 4 drugs
| Hydrocodone-Acetaminophen | 98 | $631 | $6 |
| Tramadol | 46 | $263 | $6 |
| Meloxicam | 32 | $200 | $6 |
| Oxycodone-Acetaminophen | 18 | $150 | $8 |
2018: 5 drugs
| Hydrocodone-Acetaminophen | 93 | $637 | $7 |
| Meloxicam | 36 | $251 | $7 |
| Gabapentin | 16 | $205 | $13 |
| Cefadroxil | 12 | $179 | $15 |
| Tramadol | 19 | $126 | $7 |
2017: 4 drugs
| Hydrocodone-Acetaminophen | 64 | $681 | $11 |
| Meloxicam | 48 | $324 | $7 |
| Cefadroxil | 14 | $158 | $11 |
| Oxycodone | 11 | $127 | $12 |
2016: 4 drugs
| Oxycodone | 40 | $368 | $9 |
| Hydrocodone-Acetaminophen | 14 | $100 | $7 |
| Ondansetron | 16 | $56 | $3 |
| Cephalexin | 18 | $49 | $3 |
Money from drug and device companies
$15 in 2021
| 2021 | 1 | 1 | None | $15 |
| 2020 | 2 | 2 | $200 | $200 |
| 2019 | 1 | 1 | None | $69 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Swanson | $15 | 1 payment
|
See the published payment
| Stryker | Meals · 2021-03-04 | Swanson | $15 |
See earlier years (2020, 2019)
2020: $200
| Medtronic USA | None | $150 | 1 payment
|
| Trice Medical | Segway Blade Or Mieye Camera | $50 | 1 payment
|
2019: $69
| Axogen | Axoguard Nerve Connector | $69 | 1 payment
|
Professional record
- NPI
- 1346481256
- Licence
- CA 137182California A137182: Current · expires 2027-04-30
- Trained
- Harvard Medical School, 2009 · 17 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2086S0105X (2086S0105X)
- Mailing address
- 5767 W Century Blvd, Suite 400, Los Angeles, CA, 90045
- NPI first listed
- 2009-03-23
- NPI last updated
- 2021-12-16
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.